These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 2549882)
1. [Clinical significance of serum NCC-ST 439 as a tumor marker for colorectal cancer]. Yamaguchi A; Kurosaka Y; Ohta N; Kamata T; Ishida T; Nishimura G; Katoh M; Kosaka T; Yonemura Y; Miyazaki I Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2645-50. PubMed ID: 2549882 [TBL] [Abstract][Full Text] [Related]
2. [The expression of NCC-ST-439, a tumor marker, in human breast cancer patients]. Miyahara E; Toi M; Wada T; Yamada H; Osaki A; Yanagawa E; Toge T Gan No Rinsho; 1990 Sep; 36(11):2023-6. PubMed ID: 2232168 [TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of serum level of NCC-ST-439 as a new tumor marker for colorectal diseases--fluctuation of serum NCC-ST-439 in patients with colorectal cancers before and after surgery]. Sakurai Y; Kodaira S; Teramoto T; Sugano K; Abe O; Ohtake H; Iri H Gan To Kagaku Ryoho; 1989 Sep; 16(9):3205-12. PubMed ID: 2782914 [TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of a tumor marker NCC-ST-439 in breast cancer--a comparative study with CA 15-3, CEA and TPA]. Okamura Y; Takatsuka Y; Katoh T; Tsumura I; Kobayakawa K; Kawahara T Gan To Kagaku Ryoho; 1991 Jul; 18(8):1279-85. PubMed ID: 2069399 [TBL] [Abstract][Full Text] [Related]
5. [Study on the clinical usefulness of NCC-ST-439 in cases of digestive tract cancer]. Anzai K; Kurihara M; Izumi T Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1437-47. PubMed ID: 2212836 [TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of a combination assay of CEA, CA-19-9 and TPA in patients with colorectal cancer]. Nishida O; Shiroto H; Satoh N; Nakajima Y; Manabe K; Kondoh Y; Sano F; Uchino J Gan No Rinsho; 1988 Aug; 34(9):1096-100. PubMed ID: 3172515 [TBL] [Abstract][Full Text] [Related]
7. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases. Chen C; Chen LQ; Yang GL; Li Y Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322 [TBL] [Abstract][Full Text] [Related]
8. A comparative analysis of the serum levels of NCC-ST-439, CEA and CA19-9 in patients with colorectal carcinoma. Iemura K; Moriya Y Eur J Surg Oncol; 1993 Oct; 19(5):439-42. PubMed ID: 8405479 [TBL] [Abstract][Full Text] [Related]
9. Serological studies on CEA, CA 19-9, STn and SLX in colorectal cancer. Sato T; Nishimura G; Nonomura A; Miwa K; Miyazaki I Hepatogastroenterology; 1999; 46(26):914-9. PubMed ID: 10370638 [TBL] [Abstract][Full Text] [Related]
10. [The value of tumor markers in colorectal cancer]. Peters KM; Grundmann R Leber Magen Darm; 1989 Jan; 19(1):18-25. PubMed ID: 2927234 [TBL] [Abstract][Full Text] [Related]
11. Preoperative serum level of CA19-9 predicts recurrence after curative surgery in node-negative colorectal cancer patients. Nakagoe T; Sawai T; Tsuji T; Jibiki MA; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K Hepatogastroenterology; 2003; 50(51):696-9. PubMed ID: 12828063 [TBL] [Abstract][Full Text] [Related]
12. [Study on the clinical usefulness of NCC-ST-439 in breast cancer]. Takahashi H; Nakanishi K; Taguchi K; Hasumi T; Hamada H; Sasaki F; Hata Y; Uchino J Gan To Kagaku Ryoho; 1991 Feb; 18(2):245-9. PubMed ID: 1992918 [TBL] [Abstract][Full Text] [Related]
13. [Detection and clinical study of serum tumor markers in patients with colorectal cancer]. Zhao XW; Jiang B; Han CZ; Jing JX Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):286-8. PubMed ID: 15996321 [TBL] [Abstract][Full Text] [Related]
14. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer. Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401 [TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of four tumor markers (CEA, TPA, CA50 and CA72-4) in colorectal cancer]. Koizumi F; Odagiri H; Fujimoto H; Kawamura T; Ishimori A Rinsho Byori; 1992 May; 40(5):523-8. PubMed ID: 1507478 [TBL] [Abstract][Full Text] [Related]
16. [Clinical study of the NCC-ST-439 EIA kit using serum from patients with various types of cancer and benign disease (2)]. Ohkura H; Hattori N; Miyazaki I; Sawabu N; Tobe R; Kawai K; Abe O; Ishii M; Kawai T; Kamano T Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1907-12. PubMed ID: 2439021 [TBL] [Abstract][Full Text] [Related]
17. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers. Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125 [TBL] [Abstract][Full Text] [Related]
18. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer. Griesenberg D; Nürnberg R; Bahlo M; Klapdor R Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173 [TBL] [Abstract][Full Text] [Related]
19. [Gastrointestinal cancer]. Takahashi Y Gan To Kagaku Ryoho; 2004 Aug; 31(8):1275-9. PubMed ID: 15332558 [TBL] [Abstract][Full Text] [Related]
20. [Study on carbohydrate antigen NCC-ST-439 in breast cancer]. Suzuki S; Nihei M; Nomizu T; Watanabe T; Kimijima I; Tsuchiya A; Abe R Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):1019-26. PubMed ID: 2202768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]